Keith Woods X4 Pharmaceuticals, Inc (XFOR) insider trading activity

XFOR Quotes by TradingView

Keith Woods is Director of X4 Pharmaceuticals, Inc. Currently has a direct ownership of 6,000 shares of XFOR, which is worth approximately $8,880. The most recent transaction as insider was on Jun 09, 2025, when has been sold 1,500 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 6K
95.56% 3M change
95.56% 12M change
Total Value Held $8,880

Keith Woods Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 09 2025
BUY
Grant, award, or other acquisition
-
1,500 Added 20.0%
6,000 Common Stock
Jun 10 2024
BUY
Grant, award, or other acquisition
-
45,000 Added 25.0%
135,000 Common Stock
Oct 16 2023
BUY
Grant, award, or other acquisition
-
90,000 Added 50.0%
90,000 Common Stock

Also insider at

RCKT
ROCKET PHARMACEUTICALS, INC. Healthcare
SRRK
Scholar Rock Holding Corp Healthcare
Chief Operating Officer
TCRX
TScan Therapeutics, Inc. Healthcare
KW

Keith Woods

Director
Boston, MA

Track Institutional and Insider Activities on XFOR

Follow X4 Pharmaceuticals, Inc and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells XFOR shares.

Notify only if

Insider Trading

Get notified when an X4 Pharmaceuticals, Inc insider buys or sells XFOR shares.

Notify only if

News

Receive news related to X4 Pharmaceuticals, Inc

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on XFOR